Table 2.
Gluten Group (n = 17) | Placebo Group (n = 27) | ∆Intergroup Analysis | |||||
---|---|---|---|---|---|---|---|
GI Disorders | Basal | Final | p | Basal | Final | p | |
Abdominal pain | 2 (1–2) | 1 (0–1) | 0.013 | 1 (0.5–2) | 0 (0–1) | 0.001 | ns |
Bloating | 1 (0–2) | 1 (0–1) | 0.033 | 2 (1–3) | 1 (0–2) | 0.000 | ns |
Flatulence | 1 (1–2) | 1 (0–1) | 0.008 | 2 (2–3) | 1 (0–2) | 0.001 | ns |
Diarrhea | 1 (0–1) | 0 (0–0) | 0.008 | 0 (0–2) | 0 (0–0) | 0.004 | ns |
Stomach sounds | 1 (0–2) | 0 (0–1) | 0.031 | 2 (1–2) | 0 (0–1) | 0.000 | ns |
Reduced consistency | 1 (1–2) | 0 (0–1) | 0.003 | 1 (0–2) | 0 (0–0) | 0.001 | ns |
Constipation | 0 (0–1) | 1 (0–1) | 0.305 | 0 (0–1.5) | 0 (0–1) | 0.177 | ns |
Urge to defecate | 1 (0–2) | 0 (0–1) | 0.031 | 1 (0–2.5) | 0 (0–1) | 0.056 | ns |
Incomplete evacuation | 1 (0–2) | 1 (0–2) | 0.886 | 1 (0.5–2) | 1 (0–1) | 0.033 | ns |
Nausea | 1 (0–2) | 0 (0–0) | 0.021 | 0 (0–0) | 0 (0–0) | 0.125 | ns |
Burning | 0 (0–1) | 0 (0–1) | 0.480 | 0 (0–1) | 0 (0–1) | 0.109 | ns |
Belching | 1 (0–2) | 0 (0–1) | 0.021 | 1 (0–1) | 0 (0–1) | 0.388 | ns |
Acid regurgitation | 0 (0–1) | 0 (0–0) | 0.375 | 0 (0–0.5) | 0 (0–0.5) | 1 | ns |
Epigastric pain | 0 (0–2) | 0 (0–0) | 0.068 | 0 (0–1) | 0 (0–0) | 0.017 | ns |
Depositions | 3.24 ± 2.02 | 2.76 ± 1.79 | 0.290 | 3 (2–6) | 3 (1–4.5) | 0.454 | ns |
Bristol stool scale | 4.24 ± 1.09 | 3.29 ± 1.53 | 0.016 | 4 (4–5) | 4 (2.5–4) | 0.047 | ns |
All bold show significant data. ns: not significant.